245 related articles for article (PubMed ID: 19172424)
1. Invasive prenatal diagnostic practice in Denmark 1996 to 2006.
Vestergaard CH; Lidegaard Ø; Tabor A
Acta Obstet Gynecol Scand; 2009; 88(3):362-5. PubMed ID: 19172424
[TBL] [Abstract][Full Text] [Related]
2. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
3. Declining invasive prenatal diagnostic procedures: A comparison of tertiary hospital and national data from 2012 to 2015.
Johnson K; Kelley J; Saxton V; Walker SP; Hui L
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):152-156. PubMed ID: 28295165
[TBL] [Abstract][Full Text] [Related]
4. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
5. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
6. Trends in prenatal screening and diagnostic testing among women referred for advanced maternal age.
Nakata N; Wang Y; Bhatt S
Prenat Diagn; 2010 Mar; 30(3):198-206. PubMed ID: 20063323
[TBL] [Abstract][Full Text] [Related]
7. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
8. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
Chasen ST; McCullough LB; Chervenak FA
Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
[TBL] [Abstract][Full Text] [Related]
9. Risk of fetal loss associated with invasive testing following combined first-trimester screening for Down syndrome: a national cohort of 147,987 singleton pregnancies.
Wulff CB; Gerds TA; Rode L; Ekelund CK; Petersen OB; Tabor A;
Ultrasound Obstet Gynecol; 2016 Jan; 47(1):38-44. PubMed ID: 26581188
[TBL] [Abstract][Full Text] [Related]
10. Down syndrome screening in the United States in 2001 and 2007: a survey of maternal-fetal medicine specialists.
Fang YM; Benn P; Campbell W; Bolnick J; Prabulos AM; Egan JF
Am J Obstet Gynecol; 2009 Jul; 201(1):97.e1-5. PubMed ID: 19467637
[TBL] [Abstract][Full Text] [Related]
11. Prospective audit of a one-centre combined nuchal translucency and triple test programme for the detection of trisomy 21.
Babbur V; Lees CC; Goodburn SF; Morris N; Breeze AC; Hackett GA
Prenat Diagn; 2005 Jun; 25(6):465-9. PubMed ID: 15966036
[TBL] [Abstract][Full Text] [Related]
12. Association of combined first-trimester screen and noninvasive prenatal testing on diagnostic procedures.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Obstet Gynecol; 2014 Jun; 123(6):1303-1310. PubMed ID: 24807333
[TBL] [Abstract][Full Text] [Related]
13. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older.
Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G
Obstet Gynecol; 2001 Jun; 97(6):916-20. PubMed ID: 11384696
[TBL] [Abstract][Full Text] [Related]
14. Changes in the utilization of prenatal diagnosis.
Benn PA; Egan JF; Fang M; Smith-Bindman R
Obstet Gynecol; 2004 Jun; 103(6):1255-60. PubMed ID: 15172861
[TBL] [Abstract][Full Text] [Related]
15. [Down's syndrome risk assessment in Denmark--secondary publication].
Ekelund CK; Andersen HJ; Christensen J; Ersbak V; Farlie R; Henriques C; Holmskov A; Jensen LN; Jørgensen FS; Hessellund A; Larsen T; Olesen AW; Pedersen OB; Poulsen H; Ramb J; Skibsted L; Skovbo P; Sommer S; Sperling L; Sundberg K; Juul SV; Zingenberg H; Tabor A
Ugeskr Laeger; 2010 Jun; 172(23):1759-61. PubMed ID: 20552746
[TBL] [Abstract][Full Text] [Related]
16. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
[TBL] [Abstract][Full Text] [Related]
17. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population.
Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K
Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220
[TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of the Hong Kong Hospital Authority universal Down syndrome screening programme.
Sahota DS; Leung WC; Chan WP; To WW; Lau ET; Leung TY
Hong Kong Med J; 2013 Apr; 19(2):101-8. PubMed ID: 23535668
[TBL] [Abstract][Full Text] [Related]
19. National screening guidelines and developments in prenatal diagnoses and live births of Down syndrome in 1973-2016 in Denmark.
Lou S; Petersen OB; Jørgensen FS; Lund ICB; Kjaergaard S; ; Vogel I
Acta Obstet Gynecol Scand; 2018 Feb; 97(2):195-203. PubMed ID: 29194566
[TBL] [Abstract][Full Text] [Related]
20. Fetal chromosomal abnormalities: antenatal screening and diagnosis.
Anderson CL; Brown CE
Am Fam Physician; 2009 Jan; 79(2):117-23. PubMed ID: 19178062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
